Guardant Health (GH) Cash from Operations (2017 - 2026)

Guardant Health has disclosed Cash from Operations across 10 years of filings, most recently posting -$57.8 million for Q2 2026.

• In Q2 2026, Cash from Operations rose 4.16% year-over-year to -$57.8 million; the TTM figure through Jun 2026 stood at -$185.2 million (up 22.37% YoY), while the FY2025 annual figure was -$184.8 million, up 22.97% from the prior year.
• Cash from Operations came in at -$57.8 million for Q2 2026 at Guardant Health, up from -$65.6 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of -$26.4 million in Q4 2025 to a low of -$111.9 million in Q2 2022.
• Average Cash from Operations over 5 years is -$65.7 million, with a median of -$65.1 million recorded in 2024.
• Year-over-year, Cash from Operations slumped 160.11% in 2023 and surged 59.32% in 2024.
• Over 5 years, Cash from Operations stood at -$90.7 million in 2022, then gained by 13.25% to -$78.7 million in 2023, then grew by 18.06% to -$64.5 million in 2024, then jumped by 59.12% to -$26.4 million in 2025, then plunged by 119.08% to -$57.8 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$57.8 million in Q2 2026, -$65.6 million in Q1 2026, and -$26.4 million in Q4 2025.